6-Bromo-8-chloro-[1,2,4]triazolo[1,5-a]pyridine, 98%, 250mg

n-Methylpyrrolidine-2-carboxamide hydrochloride, 95+%, 1g

3-BROMO-5-(TRIFLUOROMETHYL)-1H-INDAZOLE, 95%, 1g

2-Hydroxybutanamide, 95%, 1g

2,5,8,11,14,17,20,23,26-Nonaoxanonacosan-29-oic acid, 95%, 5g

(2E)-3-(3-chlorophenyl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

4'-fluoro-3-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

2-(3,4-dihydroquinolin-1(2H)-yl)ethanamine, 95.0%, 5g

Hexanal>98.0%(GC)100mL

tert-Butyl 1,3-dioxo-2,7-diazaspiro[4.5]decane-7-carboxylate, 97%, 100mg

trans,trans-4-(3,4-Difluorophenyl)-4'-butyl-bicyclohexyl, 97%, 100g

N-Methylmorpholine, min 98.5%, for synthesis, 250mL, glass packaging

o-Dianisidine>95.0%(HPLC)25g